Cross-Sector entity

Enphase Energy

Company ENPH
5.2

That works out to roughly 3 stories per week across a 26-day span. The busiest single day carried 4. Enphase Energy is most often covered alongside Nektar Therapeutics, which appears in 4 of these 11 stories. The clearest coverage concentration is regulation: 5 of 11 stories, with the rest divided among 4 other categories.

11 verified stories tracked

Last mentioned: Mar 22, 2026

Entity pulse

Recent coverage · Enphase Energy

11 stories
5.2 avg impact
9% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 9 percentage points.

  • 9% positive
  • 91% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Enphase Energy

That works out to roughly 3 stories per week across a 26-day span. The busiest single day carried 4. Enphase Energy is most often covered alongside Nektar Therapeutics, which appears in 4 of these 11 stories. The clearest coverage concentration is regulation: 5 of 11 stories, with the rest divided among 4 other categories. The tracked stories average 2.6 original sources each. 0% of these stories carry negative sentiment. This profile follows 11 Cross-Sector stories mentioning Enphase Energy across the period from February 25, 2026 to March 22, 2026.

Stories tracked
11
Per week
3
Negative
0%
Sources per story
2.6

Computed from the 11 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Enphase Energy. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Enphase Energy (ENPH) Deadline

    Final day for investors to move for lead plaintiff status in the ENPH securities class action.

  2. Lead Plaintiff Deadline

    Final date for investors to petition the court to lead the Enphase class action.

  3. Picard Medical (PMI) Deadline

    Final day for investors to move for lead plaintiff status in the PMI securities class action.

  4. Paysafe (PSFE) Deadline

    Final day for investors to move for lead plaintiff status in the PSFE securities class action.

  5. Enphase Suit Filed

    Pomerantz LLP files class action litigation against Enphase Energy in federal court.

  6. Litigation Expansion

    Pomerantz confirms additional filings and alerts for Enphase and Nektar Therapeutics.

  7. Enphase Energy Filing

    Pomerantz LLP files a separate class action against Enphase Energy alleging securities fraud.

  8. Secondary Nektar Notice

    A follow-up announcement clarifies the class period and lead plaintiff deadline for Nektar investors.

  9. Nektar Litigation Announced

    Pomerantz LLP announces the first class action filing against Nektar Therapeutics.

  10. Insider Sale

    Director Thurman Rodgers sells 137,250 shares of Enphase stock.

  11. Nektar Financial Update

    Nektar files updated results of operations and financial condition reports.

  12. Initial Filing

    Pomerantz LLP commences class action proceedings against Enphase Energy.

  13. Legal Notices Issued

    Faruqi & Faruqi, LLP issues formal reminders for class action deadlines.

  14. Paysafe Earnings

    Paysafe reports mixed Q4 2025 results and issues FY26 outlook.

  15. EnergySage Report Release

    The 20th Marketplace Report documents the historic shift and record storage attachment rates.

  16. Nektar Disclosure

    Nektar Therapeutics issues Regulation FD disclosure regarding its business operations.

  17. Enphase Financials

    Enphase Energy files results of operations with the SEC, highlighting market challenges.

  18. Incentive Expiration

    Key federal or state-level energy credits expire, leading to a final rush of installations.

  19. Incentive Awareness Peaks

    Consumers begin accelerating solar and storage projects in anticipation of 2026 expirations.

  20. Partnership Termination

    BMS and Nektar officially end their global clinical development collaboration.

Stories mentioning Enphase Energy 11

Finance regulation Neutral 5

Pomerantz LLP Targets Nektar and Enphase in New Securities Class Actions

Pomerantz LLP has initiated class action litigation against Nektar Therapeutics and Enphase Energy, alleging securities fraud and misleading statements. These filings highlight a growing trend of legal scrutiny in the biotech and renewable energy sectors as companies navigate volatile market conditions and regulatory shifts.

3 sources
Climate regulation Neutral 5

Pomerantz LLP Initiates Securities Class Action Against Enphase Energy

Pomerantz LLP has filed a class action lawsuit against solar technology leader Enphase Energy, alleging securities law violations following a period of significant stock volatility. The litigation marks a critical regulatory challenge for the renewable energy sector as it navigates a broader market downturn.

3 sources
Biotech pharma Neutral 5

Pomerantz LLP Files Class Action Against Nektar Therapeutics Over Disclosures

Pomerantz LLP has initiated class action litigation against Nektar Therapeutics, alleging the company made false or misleading statements regarding its clinical programs and business prospects. The lawsuit seeks to recover damages for investors following significant stock volatility linked to the company's oncology pipeline performance.

3 sources
Finance regulation Neutral 5

Securities Class Action Deadlines Loom for Paysafe, Enphase, and Picard Medical

Faruqi & Faruqi, LLP has issued critical reminders for investors in Paysafe, Picard Medical, and Enphase Energy regarding upcoming lead plaintiff deadlines in April 2026. These legal actions follow periods of financial reporting and market volatility, signaling a tightening of regulatory and investor oversight for these entities.

3 sources
Finance markets Neutral 5

Policy-Driven Growth: Green Energy and Cannabis Stocks Gain Momentum

Market analysts are highlighting green energy and cannabis as key sectors for 2026, driven by regulatory shifts and maturing business models. As interest rates stabilize, these policy-sensitive industries are attracting renewed investor interest as they transition from speculative plays to fundamental value.

2 sources
Climate market trends Neutral 5

Green Energy Stocks: Navigating Market Volatility and Policy Shifts in 2026

As the renewable energy sector navigates a complex landscape of fluctuating interest rates and evolving federal policy, specific stocks in solar, wind, and storage are emerging as key indicators of market health. This briefing examines the performance and outlook for top-tier green energy players amid a broader shift toward grid modernization.

2 sources

Source: dailypolitical.com · tickerreport.com